InvestorsHub Logo
icon url

QL300

10/08/23 8:00 AM

#638601 RE: eagle8 #638588

Yes, GBM would be an additional $3+ billion to that number. If they can use DCVax to somehow extend their patents, then DCvax becomes essential to Merck.
icon url

RobotDroid

10/08/23 9:54 AM

#638619 RE: eagle8 #638588

They do seem to be in need of nwbo.
icon url

TTsr

10/08/23 11:15 AM

#638637 RE: eagle8 #638588

Thx e8! Also remember that by Keytruda’s patent expiration in 2028, expected sales will be $30B; the ONLY $30B brand on the market!!! Currently, there is no other brand projected to be selling even $20B/annually by 2028!!! I would add: brands NOT CURRENTLY approved;)!